$ULTA — HOLD 📊 | 6 MONTHS THESIS

$ULTA — HOLD 📊 | 6 MONTHS THESIS 🎯 FQ1 FY2027 (ends Apr) | reported Jun 02 | Rev $3.2B | EPS $7.74 vs $6.90 🟢 | Margin 14.2% 💡 The market expected $6.90 EPS; the actual $7.74 closed that gap. Now, the stock's modest forward upside hinges on whether earnings can sustain double-digit growth to justify a higher multiple—an assumption not yet supported by guidance. 🏢 Business Quality: 7/10 📊 Valuation: fair — 15.8x trailing P/E is in line with specialty retail peers and historical averages; EV/EBITDA ~8x (net cash of $21M) and FCF yield of ~1%... 🔮 Catalyst: FQ1 FY2027 earnings already reported on Jun 2 ⚖️ hold: the easy money was made on the beat; now the stock is fairly priced, so wait for a pullback or a new catalyst before adding.

🎯 FQ1 FY2027 (ends Apr) | reported Jun 02 | Rev $3.2B | EPS $7.74 vs $6.90 🟢 | Margin 14.2%